- Report
- December 2022
- 115 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- November 2022
- 117 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- February 2024
- 104 Pages
Europe
From €2602EUR$2,950USD£2,280GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1080EUR$1,225USD£947GBP
€2161EUR$2,450USD£1,893GBP
- Report
- May 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,207GBP
From €3087EUR$3,500USD£2,705GBP
From €3087EUR$3,500USD£2,705GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3087EUR$3,500USD£2,705GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3087EUR$3,500USD£2,705GBP
- Report
- November 2024
- 180 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- November 2024
- 183 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- October 2024
- 134 Pages
North America
From €3528EUR$4,000USD£3,091GBP
- Report
- October 2024
- 82 Pages
Saudi Arabia
From €3087EUR$3,500USD£2,705GBP
- Report
- September 2024
- 82 Pages
Japan
From €3087EUR$3,500USD£2,705GBP
- Report
- August 2024
- 80 Pages
United States
From €3087EUR$3,500USD£2,705GBP
- Report
- August 2024
- 80 Pages
Japan
From €3087EUR$3,500USD£2,705GBP
- Report
- August 2024
- 187 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- July 2024
- 180 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- July 2024
- 80 Pages
India
From €3087EUR$3,500USD£2,705GBP
- Report
- July 2024
- 189 Pages
Global
From €3969EUR$4,500USD£3,478GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more